InvestorsHub Logo
Followers 53
Posts 1783
Boards Moderated 0
Alias Born 03/22/2015

Re: None

Wednesday, 05/13/2015 1:08:44 PM

Wednesday, May 13, 2015 1:08:44 PM

Post# of 403134
ADF Wars: Here Comes Pfizer!

This e-mail from Pfizer just appeared in my inbox. I have previously documented how Pfizer has been working with non-commercial entities, specifically an organization called Rethink Opioids, to re-educate prescribers to think about prescribing an ADF opioid as a "Universal Precaution." The previous e-mails have been from third-parties and have been free of commercial influence. As I predicted, now comes Pfizer with specific details of the agonist-antagonist ADF Embeda.




Nasrat Hakim:

Number two when a company like Pfizer embraces the technology which little Elite has that would tell you that we have as a gold cup, okay. So this is how I look at it, it’s very positive, this is a wonderful thing that little Elite has the same thing that Pfizer had and maybe a little better and second Pfizer is paving the way for us, another giant is going to jump in and want to partner with us down the road in order to compete with Pfizer.




My previous post:


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112929084


This is a perfect example of what NH was saying. Completely in the background, Pfizer has started to introduce the idea of prescribing only ADF-opioids. Below is the link to Rethink Opioids. It is a very well-done site, evidence-based medicine with nil commercial influence. Play around on the site and see if you can find the section on agonist/antagonist abuse-deterrence. Not easy to find but its there, and I bet in the near future I'll be hearing more from Pfizer on this issue.


"There are three kinds of lies: lies, damned lies, and statistics."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News